Evidence map›Paper›PMID 31933753›Full record

ArticleInternational journal of clinical and experimental pathology2019

Primary sclerosing epithelioid fibrosarcoma of chest wall in a patient with breast cancer: a case report.

Shuang Zhang, Yinhua Zhang, Li Guo, Hong Zhang, Yanfei Yu, Dong Li, Ling Xu, Xuening Duan, Yinhua Liu, Ting Li

Open access · greenAbstract readCase Reports
PubMed Full text at PMC
In one paragraph

Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Metastatic pediatric sclerosing epithelioid fibrosarcoma.Cold Spring Harbor molecular case studies · 2021
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shuang ZhangDepartment of Pathology, Peking University First Hospital Beijing, China.
Yinhua ZhangDepartment of Pathology, Peking University First Hospital Beijing, China.
Li GuoDepartment of Radiology, Peking University First Hospital Beijing, China.
Hong ZhangDepartment of Pathology, Peking University First Hospital Beijing, China.
Yanfei YuDepartment of Pathology, Peking University First Hospital Beijing, China.
Dong LiDepartment of Pathology, Peking University First Hospital Beijing, China.
Ling XuDepartment of Breast Disease Center, Peking University First Hospital Beijing, China.
Xuening DuanDepartment of Breast Disease Center, Peking University First Hospital Beijing, China.
Yinhua LiuDepartment of Breast Disease Center, Peking University First Hospital Beijing, China.
Ting LiDepartment of Pathology, Peking University First Hospital Beijing, China.
Peking University · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sclerosing epithelioid fibrosarcoma (SEF) is a rare neoplasm mostly arising in limbs and limb girdles, with a high rate of recurrence. Herein, we describe a rare case of primary SEF in the chest wall with concurrent breast cancer. A 41-year-old female was found to have an asymptomatic mass in the upper chest wall on magnetic resonance imaging that was performed for breast cancer. Histology of the resected tumor showed features of SEF, with epithelioid cells arranged in nests or a retiform pattern within a sclerosing stroma. By immunohistochemistry, the tumor cells showed staining for vimentin and epithelial membrane antigen, and were negative for cytokeratin.

Indexed as

breast cancerchest wallSclerosing epithelioid fibrosarcoma

Identifiers

PMID31933753
PMCPMC6944016
OpenAlexW3026221084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.